AnaptysBio
ANAB
ANAB
134 hedge funds and large institutions have $2.53B invested in AnaptysBio in 2018 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 43 increasing their positions, 43 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
0% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 43
25% less call options, than puts
Call options by funds: $40.7M | Put options by funds: $54.1M
Holders
134
Holding in Top 10
7
Calls
$40.7M
Puts
$54.1M
Top Buyers
| 1 | +$52.3M | |
| 2 | +$47.9M | |
| 3 | +$35.8M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$32.5M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$31.6M |
Top Sellers
| 1 | -$56.5M | |
| 2 | -$54M | |
| 3 | -$37M | |
| 4 |
Morgan Stanley
New York
|
-$29.7M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$21.7M |